Difluprednate Emulsion
Product Images NDC 69097-341

5 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Difluprednate (NDC 69097-341). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (825a55a7 Ffdf 4fde Bbb2 486cbd16e602 01)

Image (825a55a7 Ffdf 4fde Bbb2 486cbd16e602 01)
Chemical structure of Difluprednate, the active ingredient in the ophthalmic emulsion drug product by Cipla USA Inc. The structure shows detailed molecular bonds and functional groups characteristic of the corticosteroid compound.*
FDA Label Image

Image (825a55a7 Ffdf 4fde Bbb2 486cbd16e602 02)

Image (825a55a7 Ffdf 4fde Bbb2 486cbd16e602 02)
A bar chart showing the percent of subjects with anterior chamber cells clearing (cell count = 0) on Day 8 and Day 15. It compares Difluprednate QID (n=107) with placebo (n=220), indicating higher percentages for Difluprednate (22% on Day 8 and 41% on Day 15) versus placebo (8% on Day 8 and 12% on Day 15). Statistically significant differences (P<0.05) are marked.*
FDA Label Image

Image (825a55a7 Ffdf 4fde Bbb2 486cbd16e602 03)

Image (825a55a7 Ffdf 4fde Bbb2 486cbd16e602 03)
A bar chart titled 'Percent of Subjects who were Pain Free' showing comparisons between Difluprednate QID (n=107) and Placebo (n=220) over Days 3, 8, and 15. Percentages are higher for Difluprednate across all days, with statistical significance indicated (P<0.05).*
FDA Label Image

Container Label (825a55a7 Ffdf 4fde Bbb2 486cbd16e602 04)

Container Label (825a55a7 Ffdf 4fde Bbb2 486cbd16e602 04)
Label for Difluprednate Ophthalmic Emulsion 0.05%, sterile, 5 mL, by Cipla USA Inc. The label includes the NDC 69097-341-35, specifies it is Rx only for ophthalmic use, and provides manufacturing details from Cipla Ltd., India. A barcode and space for batch and expiry printing are visible.*
FDA Label Image

Carton Label (825a55a7 Ffdf 4fde Bbb2 486cbd16e602 05)

Carton Label (825a55a7 Ffdf 4fde Bbb2 486cbd16e602 05)
The packaging label for Difluprednate Ophthalmic Emulsion 0.05% features a white background with blue accents. The label shows the product name, strength, dosage form, and volume of 5 mL. It is marked for ophthalmic use only and sterile. The labeler is Cipla USA Inc. Manufacturing details indicate production by Cipla Ltd., India, and mention of Indoco Remedies Limited. Two barcodes and the NDC number 69097-341-35 are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.